Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.66p
   
  • Change Today:
      0.060p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 2,810,802
  • Market Cap: £13.27m
  • RiskGrade: 328
  • Beta: 0.05

Latest ShareCast News

ImmuPharma can't explain near-400% stock jump

By Benjamin Chiou

Date: Tuesday 28 Jan 2025

(Sharecast News) - Specialist drug discovery and development outfit ImmuPharma has said that it can't pinpoint a reason behind its share price more than quadrapling over the past month.

ImmuPharma progresses P140 clinical programme with FDA

By Josh White

Date: Wednesday 12 Apr 2023

(Sharecast News) - Drug discovery and development company ImmuPharma announced positive progress in its late-stage P140 clinical programme on Tuesday, for patients with chronic idiopathic demyelinating polyneuropathy (CIDP), a rare neurological disease with high medical need.

ImmuPharma upbeat after meeting with US partner Avion

By Josh White

Date: Friday 11 Nov 2022

(Sharecast News) - Drug discovery and development specialist ImmuPharma updated the market on a recent meeting in Atlanta with its United States partner Avion Pharmaceuticals on Friday, for strategic discussions around its 'Lupuzor' clinical programme.

ImmuPharma's US partner receives FDA response on... 14-Sep-2022 ShareCast
ImmuPharma making final preparations for Lupuzor... 04-May-2022 ShareCast
ImmuPharma surges on success in latest trial of ... 13-Apr-2022 ShareCast
ImmuPharma updates plan for trials of lupus trea... 07-Feb-2022 ShareCast
ImmuPharma raises £3.55m to fund research pipeline 20-Dec-2021 ShareCast
ImmuPharma signs two-year collaboration deal wit... 29-Nov-2021 ShareCast
ImmuPharma reports 'significant' progress since ... 18-Nov-2021 ShareCast
FDA gives ImmuPharma go-ahead for pharmacokineti... 12-Aug-2021 ShareCast
ImmuPharma clarifies next steps for phase 3 Lupu... 09-Feb-2021 ShareCast
ImmuPharma gets December date for FDA meeting 20-Nov-2020 ShareCast
ImmuPharma confirms continued FDA delays for Lup... 11-Sep-2020 ShareCast
Immupharma raises £6.5m in oversubscribed placing 02-Sep-2020 ShareCast
ImmuPharma clears 'important' regulatory hurdle ... 27-Jul-2020 ShareCast
ImmuPharma shares surge on Covid-19 potential 14-May-2020 ShareCast
ImmuPharma raises ?1.5m to fund development prog... 30-Mar-2020 ShareCast
ImmuPharma and Avion to proceed with Lupuzor pha... 06-Feb-2020 ShareCast
ImmuPharma says not looking to raise funds 11-Dec-2019 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.66p
Change Today 0.060p
% Change 2.31 %
52 Week High 5.90
52 Week Low 1.09
Volume 2,810,802
Shares Issued 499.72m
Market Cap £13.27m
Beta 0.05
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.84% below the market average28.84% below the market average28.84% below the market average28.84% below the market average28.84% below the market average
8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average
Price Trend
64.17% above the market average64.17% above the market average64.17% above the market average64.17% above the market average64.17% above the market average
82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 30-May-2025

Time Volume / Share Price
16:26 6,102 @ 2.61p
16:14 100,000 @ 2.73p
16:13 100,000 @ 2.72p
16:10 100,000 @ 2.60p
16:08 75,000 @ 2.73p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page